Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study.

ABSTRACT:

Background

In this study, we evaluated the effects of various medications on the patency of vascular access (VA) for hemodialysis.

Methods

We analyzed data from the Longitudinal Health Insurance Database of Taiwan. We adopted a case-control study design within a cohort of patients who had received regular hemodialysis between 2002 and 2012; 34,354 patients with first VA failure were identified, and the duration from VA creation date to the first VA failure date was calculated. We then classified these patients into two groups, namely arteriovenous fistula (AVF, n = 25,933) and arteriovenous graft (AVG, n = 8,421). Each group was further divided into two subgroups, namely short-term (<1 year) and long-term (≥1 year) patency.

Results

The risk factors for early VA failur

SUBMITTER: Hsu YH 

PROVIDER: S-EPMC6193726 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature